- February 21, 2012
- Plexxikon receives European approval for Zelboraf
- February 21, 2012
- Diabetes drug developer Lumena raises $2.5M; compound regulates blood sugar
- February 16, 2012
- First and Only Personalized Treatment for Deadliest Form of Skin Cancer Approved by Health Canada
- February 6, 2012
- Transplant antiviral strong in phase 2; Chimerix plans phase 3 start this year
- February 2, 2012
- Athersys, Inc. Announces Positive Results of MultiStem(R) Clinical Trial for Hematopoietic Stem Cell Transplant Support and Prevention of Graft-Versus-Host Disease
- January 27, 2012
- Chimerix Announces Presentation of Final Data from CMX001 Phase 2 Trial in Prophylaxis of Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
- January 19, 2012
- Researchers uncover how new melanoma drug accelerates secondary skin cancers
- January 19, 2012
- PRINTed Nanoparticles Delivery Multiple Punches to Treat Prostate Cancer
- January 4, 2012
- Achillion hepatitis drug gets faster FDA review